Global Glioblastoma Treatment Drugs Market Report By Type (VEGF/VEGFR Inhibitor, Alkylating Agents And Miscellaneous Antineoplastic), Distribution Channel (Hospital, Cancer Research Organization, Long Term Care Center And Diagnostic Centers) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2019-2026
ID:VMR11210609
January 2020
Report Formats:

As per this study, the Global Glioblastoma Treatment Drugs Market was valued USD XX.X MN (by revenue) in 2019 and is anticipated to reach USD XX.X MN by 2026 with a CAGR of X.X%.

Glioblastoma also is known as glioblastoma multiforme, is a type of malignant brain tumor that develops from glial cells. It proliferates at a rapid rate and is difficult to cure however; the treatment drugs are often prescribed to ease the symptoms. Common symptoms are a constant headache, nausea, personality changes, blurred vision and loss of appetite. VEGF/VEGFR Inhibitors, Alkylating Agents and Miscellaneous Antineoplastic
agents are used to treat glioblastoma.

Market Dynamics
 
Rising elderly population followed by an increase in the prevalence of cancer is driving the market growth. Increased funding to the companies performing research for the development of more effective drugs is further fueling the market growth. Also, ongoing R&D in gene therapy and molecular biotechnology for treating brain and spine-related disorders is likely to push the market growth. Despite this, relatively higher expenditure for GBM treating drugs is the key challenge for the market growth.
 
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of glioblastoma treatment drugs.
 
Market Segmentation
 
The broad glioblastoma treatment drugs market has been sub-grouped into type and distribution channel. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
 
By Type

  • VEGF/VEGFR Inhibitor
  • Alkylating Agents
  • Miscellaneous Antineoplastic
 
By Distribution Channel
  • Hospital
  • Cancer Research Organization
  • Long Term Care Center
  • Diagnostic Centers
 
Regional Analysis
 
Furthermore, the report comprises of the geographical segmentation, which mainly focuses on current and forecast demand for glioblastoma treatment drugs in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
 
Europe Glioblastoma Treatment Drugs Market By Revenue (USD MN)
 

 
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the glioblastoma treatment drugs market include Arbor Pharms LLC., Bristol-Myers Squibb Company, Emcure Pharmaceuticals Ltd., F. Hoffmann-La Roche AG, Merck & Co., Inc., Sandoz, and Sigma-Tau Pharmaceuticals, Inc.
among others. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
 
 
METHODOLOGY:
 
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Glioblastoma Treatment Drugs Market
       2.2. Global Glioblastoma Treatment Drugs Market Snapshot
 
3 . GLIOBLASTOMA TREATMENT DRUGS – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Glioblastoma Treatment Drugs Market
       3.3. Market Restraints of Glioblastoma Treatment Drugs Market
       3.4. Opportunities of Glioblastoma Treatment Drugs Market
       3.5. Trends of Glioblastoma Treatment Drugs Market
       3.6. Porter’s Five Force Analysis of Glioblastoma Treatment Drugs Market
       3.7. Glioblastoma Treatment Drugs Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Distribution Channel
           3.7.3 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Glioblastoma Treatment Drugs Value Chain Analysis
       4.2. Glioblastoma Treatment Drugs Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Glioblastoma Treatment Drugs Raw Material Manufactures List
           4.2.3. Price Trend of Glioblastoma Treatment Drugs Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . GLOBAL GLIOBLASTOMA TREATMENT DRUGS MARKET ANALYSIS BY TYPE
       5.1 Overview by Type
       5.2 Global Glioblastoma Treatment Drugs Market Analysis by Type
       5.3 Market Analysis of VEGF/VEGFR Inhibitor by Regions
       5.4 Market Analysis of Alkylating Agents by Regions
       5.5 Market Analysis of Miscellaneous Antineoplastic by Regions
 
6 . GLOBAL GLIOBLASTOMA TREATMENT DRUGS MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       6.1 Overview by Distribution Channel
       6.2 Global Glioblastoma Treatment Drugs Market Analysis by Distribution Channel
       6.3 Market Analysis of Hospital by Regions
       6.4 Market Analysis of Cancer Research Organization by Regions
       6.5 Market Analysis of Long Term Care Center by Regions
       6.6 Market Analysis of Diagnostic Centers by Regions
 
7 . GLOBAL GLIOBLASTOMA TREATMENT DRUGS MARKET ANALYSIS BY GEOGRAPHY
       7.1. Regional Outlook
       7.2. Introduction
       7.3. North America
           7.3.1. Overview
           7.3.2. North America Glioblastoma Treatment Drugs Market Estimate by Market Segment
           7.3.3. North America Glioblastoma Treatment Drugs Market Estimate by Country
           7.3.4. United State
           7.3.5. Rest of North America
       7.4. Europe
           7.4.1. Overview
           7.4.2. Europe Glioblastoma Treatment Drugs Market Estimate by Market Segment
           7.4.3. Europe Glioblastoma Treatment Drugs Market Estimate by Country
           7.4.4. United Kingdom
           7.4.5. France
           7.4.6. Germany
           7.4.7 Rest of Europe
       7.5. Asia Pacific
           7.5.1. Overview
           7.5.2. Asia Pacific Glioblastoma Treatment Drugs Market Estimate by Market Segment
           7.5.3. Asia Pacific Glioblastoma Treatment Drugs Market Estimate by Country
           7.5.4. China
           7.5.5. Japan
           7.5.6. India
           7.5.7. Rest of Asia Pacific
       7.6. Latin America
           7.6.1. Overview
           7.6.2. Latin America Glioblastoma Treatment Drugs Market Estimate by Market Segment
           7.6.3. Latin America Glioblastoma Treatment Drugs Market Estimate by Country
           7.6.4. Brazil
           7.6.5. Rest of Latin America
       7.7. Middle East & Africa
           7.7.1. Overview
           7.7.2. Middle East & Africa Glioblastoma Treatment Drugs Market Estimate by Market Segment
           7.7.3. Middle East & Africa Glioblastoma Treatment Drugs Market Estimate by Country
           7.7.4. Middle East
           7.7.5. Africa
 
8 . COMPETITIVE LANDSCAPE OF THE GLIOBLASTOMA TREATMENT DRUGS COMPANIES
       8.1. Glioblastoma Treatment Drugs Market Competition
       8.2. Partnership/Collaboration/Agreement
       8.3. Merger And Acquisitions
       8.4. New Product Launch
       8.5. Other Developments
 
9 . COMPANY PROFILES OF GLIOBLASTOMA TREATMENT DRUGS INDUSTRY
       9.1. Company Share Analysis
       9.2. Market Concentration Rate
       9.3. Arbor Pharms LLC.
           9.3.1. Company Overview
           9.3.2. Financials
           9.3.3. Products
           9.3.4. Recent Developments
       9.4. Bristol-Myers Squibb Company
           9.4.1. Company Overview
           9.4.2. Financials
           9.4.3. Products
           9.4.4. Recent Developments
       9.5. Emcure Pharmaceuticals Ltd.
           9.5.1. Company Overview
           9.5.2. Financials
           9.5.3. Products
           9.5.4. Recent Developments
       9.6. F. Hoffmann-La Roche AG
           9.6.1. Company Overview
           9.6.2. Financials
           9.6.3. Products
           9.6.4. Recent Developments
       9.7. Merck & Co. Inc.
           9.7.1. Company Overview
           9.7.2. Financials
           9.7.3. Products
           9.7.4. Recent Developments
       9.8. Sandoz
           9.8.1. Company Overview
           9.8.2. Financials
           9.8.3. Products
           9.8.4. Recent Developments
       9.9. Sigma-Tau Pharmaceuticals Inc.
           9.9.1. Company Overview
           9.9.2. Financials
           9.9.3. Products
           9.9.4. Recent Developments
 
 *Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
 LIST OF TABLES

  •  Global Glioblastoma Treatment Drugs Market Snapshot
  •  Drivers of The Global Glioblastoma Treatment Drugs Market Impact Analysis
  •  Restraints of The Global Glioblastoma Treatment Drugs Market Impact Analysis
  •  List of Raw Material
  •  List of Raw Material Manufactures
  •  List of Potential Buyers
  •  Global Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  Global Glioblastoma Treatment Drugs Market Analysis in VEGF/VEGFR Inhibitor by Geography (USD MN)
  •  Global Glioblastoma Treatment Drugs Market Analysis in Alkylating Agents by Geography (USD MN)
  •  Global Glioblastoma Treatment Drugs Market Analysis in Miscellaneous Antineoplastic by Geography (USD MN)
  •  Global Glioblastoma Treatment Drugs Market Analysis by Distribution Channel (USD MN)
  •  Global Glioblastoma Treatment Drugs Market Analysis in Hospital by Geography (USD MN)
  •  Global Glioblastoma Treatment Drugs Market Analysis in Cancer Research Organization by Geography (USD MN)
  •  Global Glioblastoma Treatment Drugs Market Analysis in Long Term Care Center by Geography (USD MN)
  •  Global Glioblastoma Treatment Drugs Market Analysis in Diagnostic Centers by Geography (USD MN)
  •  Global Glioblastoma Treatment Drugs Market by Geography (USD MN)
  •  North America Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  North America Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  North America Glioblastoma Treatment Drugs Market Estimate by Country (USD MN)
  •  United State Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  United State Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  Rest of North America Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  Rest of North America Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  Europe Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  Europe Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  United Kingdom Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  United Kingdom Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  France Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  France Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  Germany Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  Germany Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  Rest of Europe Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  Rest of Europe Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  Asia Pacific Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  Asia Pacific Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  Asia Pacific Glioblastoma Treatment Drugs Market Estimate by Country (USD MN)
  •  China Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  China Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  Japan Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  Japan Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  India Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  India Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  Rest of Asia Pacific Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  Rest of Asia Pacific Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  Latin America Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  Latin America Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  Latin America Glioblastoma Treatment Drugs Market Estimate by Country (USD MN)
  •  Brazil Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  Brazil Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  Rest of Latin America Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  Rest of Latin America Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  Middle East & Africa Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  Middle East & Africa Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  Middle East & Africa Glioblastoma Treatment Drugs Market Estimate by Country (USD MN)
  •  Middle East Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  Middle East Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  Africa Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  Africa Glioblastoma Treatment Drugs Market Estimate by Distribution Channel (USD MN)
  •  Partnership/Collaboration/Agreement
  •  Mergers And Acquisiton
  •  New Product Launch
  •  Other Developments
  •  Company Market Share Analysis, 2019
 
 LIST OF FIGURES
  •  Research Scope of Glioblastoma Treatment Drugs Report
  •  Market Research Process
  •  Market Research Methodology
  •  Global Glioblastoma Treatment Drugs Market Size, by Region (USD MN)
  •  Porters Five Forces Analysis
  •  Market Attractiveness Analysis by Type
  •  Market Attractiveness Analysis by Distribution Channel
  •  Market Attractiveness Analysis by Region
  •  Value Chain Analysis
  •  Global Glioblastoma Treatment Drugs Market Analysis by Type (USD MN)
  •  Global Glioblastoma Treatment Drugs Market Analysis in VEGF/VEGFR Inhibitor by Geography (USD MN)
  •  Global Glioblastoma Treatment Drugs Market Analysis in Alkylating Agents by Geography (USD MN)
  •  Global Glioblastoma Treatment Drugs Market Analysis in Miscellaneous Antineoplastic by Geography (USD MN)
  •  Global Glioblastoma Treatment Drugs Market Analysis by Distribution Channel (USD MN)
  •  Global Glioblastoma Treatment Drugs Market Analysis in Hospital by Geography (USD MN)
  •  Global Glioblastoma Treatment Drugs Market Analysis in Cancer Research Organization by Geography (USD MN)
  •  Global Glioblastoma Treatment Drugs Market Analysis in Long Term Care Center by Geography (USD MN)
  •  Global Glioblastoma Treatment Drugs Market Analysis in Diagnostic Centers by Geography (USD MN)
  •  Latin America Glioblastoma Treatment Drugs Market by Revenue
  •  Middle East & Africa Glioblastoma Treatment Drugs Market by Revenue
  •  Recent Development in Glioblastoma Treatment Drugs Industry
  •  Company Market Share Analysis, 2019

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials